These approaches make sense as biosecurity interventions. As a biomedical engineer with biosecurity interests, I have a career interest in these questions. Here are a couple of my questions:
These options do not involve advances in bioengineering technology, and I’m assuming that this was a key criteria for your selection of these interventions. Is your analysis based on a broad heuristic of being against near-term advances in biotechnology, or if not, is there some detailed technical analysis you’re using to distinguish biorisk-increasing from biorisk-decreasing technologies?
If you are operating with a heuristic of being against near-term advances biotechnology on the basis of biorisk, do you have an explicit outside view, argument, or set of evidence on which that belief rests? If so, can you give us a sense of perspective on the amount of research you’ve done into this question?
These approaches make sense as biosecurity interventions. As a biomedical engineer with biosecurity interests, I have a career interest in these questions. Here are a couple of my questions:
These options do not involve advances in bioengineering technology, and I’m assuming that this was a key criteria for your selection of these interventions. Is your analysis based on a broad heuristic of being against near-term advances in biotechnology, or if not, is there some detailed technical analysis you’re using to distinguish biorisk-increasing from biorisk-decreasing technologies?
If you are operating with a heuristic of being against near-term advances biotechnology on the basis of biorisk, do you have an explicit outside view, argument, or set of evidence on which that belief rests? If so, can you give us a sense of perspective on the amount of research you’ve done into this question?